Literature DB >> 15660517

Severe acute respiratory syndrome (SARS): a year in review.

Danuta M Skowronski1, Caroline Astell, Robert C Brunham, Donald E Low, Martin Petric, Rachel L Roper, Pierre J Talbot, Theresa Tam, Lorne Babiuk.   

Abstract

Severe acute respiratory syndrome (SARS) emerged from China as an untreatable and rapidly spreading respiratory illness of unknown etiology. Following point source exposure in February 2003, more than a dozen guests infected at a Hong Kong hotel seeded multi-country outbreaks that persisted through the spring of 2003. The World Health Organization responded by invoking traditional public health measures and advanced technologies to control the illness and contain the cause. A novel coronavirus was implicated and its entire genome was sequenced by mid-April 2003. The urgency of responding to this threat focused scientific endeavor and stimulated global collaboration. Through real-time application of accumulating knowledge, the world proved capable of arresting the first pandemic threat of the twenty-first century, despite early respiratory-borne spread and global susceptibility. This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660517     DOI: 10.1146/annurev.med.56.091103.134135

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  72 in total

1.  What is the best control strategy for multiple infectious disease outbreaks?

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  Proc Biol Sci       Date:  2007-03-22       Impact factor: 5.349

Review 2.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

3.  The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.

Authors:  Holger A Lindner; Nasser Fotouhi-Ardakani; Viktoria Lytvyn; Paule Lachance; Traian Sulea; Robert Ménard
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  SARS-CoV regulates immune function-related gene expression in human monocytic cells.

Authors:  Wanchung Hu; Yu-Ting Yen; Sher Singh; Chuan-Liang Kao; Betty A Wu-Hsieh
Journal:  Viral Immunol       Date:  2012-08       Impact factor: 2.257

5.  The University of Washington Health Sciences Library BioCommons: an evolving Northwest biomedical research information support infrastructure.

Authors:  Mark Minie; Stuart Bowers; Peter Tarczy-Hornoch; Edward Roberts; Rose A James; Neil Rambo; Sherrilynne Fuller
Journal:  J Med Libr Assoc       Date:  2006-07

6.  Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine.

Authors:  Natalia Pogrebnyak; Maxim Golovkin; Vyacheslav Andrianov; Sergei Spitsin; Yuriy Smirnov; Richard Egolf; Hilary Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

7.  Insights into the evolution and emergence of a novel infectious disease.

Authors:  Ruben J Kubiak; Nimalan Arinaminpathy; Angela R McLean
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

Review 8.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

9.  Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.

Authors:  Yanbo Lv; Zhihua Ruan; Li Wang; Bing Ni; Yuzhang Wu
Journal:  BMC Immunol       Date:  2009-12-03       Impact factor: 3.615

10.  Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.

Authors:  Lanying Du; Guangyu Zhao; Chris C S Chan; Shihui Sun; Min Chen; Zhonghua Liu; Hongxiang Guo; Yuxian He; Yusen Zhou; Bo-Jian Zheng; Shibo Jiang
Journal:  Virology       Date:  2009-08-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.